Many of y’all are more knowledgeable about medic

Many of y’all are more knowledgeable about medicine and pharma than I am. But To me it seems like the sp doesn’t react well in the present no matter what NP says. Most of us here are pretty confident that this drug is a blessing to the world, and that the corporate governance of CytoDyn is competent. I can only imagine how hard it is to turn a company around, and to work on all these indications all while managing stock holder expectations. Maybe silence is golden, and in that case we all just need to stfu about stock prices and let the team work. We did our part as investors, now it’s up to them to run it into the end zone. We can talk about all the bad ass science behind the Leronlimab all we want, which many of y’all already do, I personally think it’s very cool just to do that.